Publication entries for cascade impactor
Pharm Res. 2012 Nov;29(11):3122-30. doi: 10.1007/s11095-012-0804-7. Epub 2012 Jul 3. Doub WH1, Adams WP, Wokovich AM, Black JC, Shen M, Buhse LF. Corresponding author: firstname.lastname@example.org 1Division of Pharmaceutical Analysis, Food and Drug Administration CDER, OPS, St. Louis, Missouri, USA. ABSTRACT PURPOSE: To determine if cascade impactor (CI) measurement of drug in small particles from aqueous nasal sprays, described in FDA’s 2003 draft Nasal […]
Journal of Pharmaceutical Sciences, 97(8):3321-3334 (August 2008). Guo C, Gillespie SR, Kauffman J, Doub WH. Corresponding author: email@example.com U.S. Food and Drug Administration, Division of Pharmaceutical Analysis, 1114 Market Street, Room 1002, St. Louis, Missouri 63101 Abstract The purpose of this research was to compare two cascade impaction devices for the aerodynamic particle size assessment of a combination metered-dose […]
Doub, WH., Adams, WP., Measurement Of Drug In Fine Particles From Aqueous Nasal Spray By Cascade Impactor. Annual Meeting of the American Association of Pharmaceutical Sciences. 2002; Poster number T3033. Contact the American Association of Pharmaceutical Scientists for further information.